Le Lézard
Classified in: Health
Subjects: SVY, TRI, DIS, SCZ, DEI

Auditory Insight Outlines Best Practices for Hearing Loss Patient's Journey


The firm's consumer-patient journey framework applies across hearing healthcare, from OTC hearing aids to genetic testing

NEW HAVEN, Conn., Aug. 17, 2023 /PRNewswire/ -- Auditory Insight, a leading consultancy for the hearing healthcare industry, analyzes the central role of the consumer-patient journey in creating market development strategies?for interventions from hearing aids to genetic testing?in its Q3 2023 Research Note.  

Download the Research Note: Go-To-Market Strategy in Hearing Healthcare - The Essential Consumer-Patient Journey.

In many hearing healthcare interventions, market development strategies focus on unmet clinician needs. Audiologists decide which hearing aid brands to recommend in their clinic, while neurotologists who perform cochlear implantation recommend genetic testing.

Far too often, the strategy development process in hearing healthcare neglects to analyze the consumer-patient journey.

"We believe that's a mistake," declares Nancy M. Williams, president of Auditory Insight. "The consumerization of healthcare, in which consumers play an active role in managing their care, is an important force. Understanding the consumer-patient journey is more essential for strategy development than ever."

Williams adds that the presence of global brands like Sony, Apple, Intel, and EssilorLuxottica in hearing aids and hearing enhancement will only accelerate the process of consumers driving their treatment.

Auditory Insight has developed a proprietary framework for analyzing the consumer-patient journey in hearing healthcare. The company deployed the framework across multiple sectors of hearing healthcare, including hearing aids, cochlear implants, and genetic testing.

The company's latest research note describes four best practices for assessing the consumer-patient journey:

  1. Conceive of the journey in its totality, from consumer-patients first becoming aware of their hearing loss until they integrate the hearing intervention into their daily lives.
  2. Focus on the consumer-patient's current journey, their actual lived experiences, including their struggles and difficulties, to find opportunities.
  3. Map the consumer journey along various dimensions; Auditory Insight uses multiple dimensions in behavioral, psychological, and structural domains.
  4. Integrate the consumer-patient journey with the experiences of other market stakeholders, like audiologists, ENTs, and genetic counselors.

Williams describes one engagement for a hearing healthcare company interested in increasing the prevalence of genetic testing. Comparing clinicians' and consumer-patients' experiences yielded tremendous insight. "We were stunned to learn that one key aspect of the clinical narrative actually suppressed patient interest in genetic testing. Audiologists and ENTs did not realize that in response to this common narrative, close to half of patients immediately shut down, ignoring recommendations," she explains.

Williams is available to discuss this research and the implications for hearing healthcare companies.

About Auditory Insight

Auditory Insight partners with senior leaders of hearing health device and pharmaceutical companies to develop successful go-to-market strategies.  The firm also advises growth equity and private equity funds on creating portfolio value in hearing healthcare.

SOURCE Auditory Insight LLC


These press releases may also interest you

at 02:05
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...

at 02:00
With Denmark as the centre of gravity, the ambition is to invest in, support and advance some of the world's most promising quantum technology companies with applications in the life sciences. The quantum industry, which develops novel technologies...

at 01:40
In a significant move to meet the growing demand for health management solutions, the 135th China Import and Export Fair ("Canton Fair" or "the Fair") has brought together top-tier companies from the Medicines, Health Products and Medical Devices...

at 00:05
As May marks Preeclampsia Awareness Month, leading maternal health experts, preeclampsia survivors and industry leaders have come together on a new campaign, "Preeclampsia Prevention is Possible." The campaign elevates awareness of a major paradigm...

30 avr 2024
The report titled "Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization &...

30 avr 2024
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online. Prof. Yuankai Shi, chief physician of...



News published on and distributed by: